WAM
PFE icon

Werlinich Asset Management’s Pfizer PFE Stock Holding History

Werlinich Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Hold
92,200
– – 0.85% 30
2026
Q1 		$2.59M Buy
92,200
+1,100
+1% +$29.3K 1.26% 28
2025
Q4 		$2.28M Sell
91,100
-1,700
-2% -$42.9K 1.12% 27
2025
Q3 		$2.36M Sell
92,800
-1,500
-2% -$37K 1.17% 25
2025
Q2 		$2.29M Sell
94,300
-4,135
-4% -$96.4K 1.25% 22
2025
Q1 		$2.49M Buy
98,435
+5,700
+6% +$149K 1.58% 21
2024
Q4 		$2.45M Buy
92,735
+2,350
+3% +$63.7K 1.43% 23
2024
Q3 		$2.62M Buy
90,385
+225
+0.2% +$6.56K 1.52% 20
2024
Q2 		$2.51M Buy
90,160
+1,350
+2% +$37.2K 1.56% 21
2024
Q1 		$2.47M Buy
88,810
+9,063
+11% +$251K 1.61% 20
2023
Q4 		$2.28M Buy
79,747
+2,197
+3% +$66.4K 1.73% 18
2023
Q3 		$2.57M Sell
77,550
-1,150
-1% -$40.7K 2.12% 16
2023
Q2 		$2.89M Buy
78,700
+1,900
+2% +$74K 2.32% 14
2023
Q1 		$3.13M Buy
76,800
+290
+0.4% +$12.5K 2.75% 11
2022
Q4 		$3.92M Buy
76,510
+365
+0.5% +$17.5K 3.63% 8
2022
Q3 		$3.33M Sell
76,145
-300
-0.4% -$14.6K 3.41% 10
2022
Q2 		$4.01M Sell
76,445
-1,000
-1% -$51K 3.75% 7
2022
Q1 		$4.01M Buy
77,445
+110
+0.1% +$5.71K 3.05% 10
2021
Q4 		$4.57M Hold
77,335
– – 3.33% 9
2021
Q3 		$3.33M Sell
77,335
-10,240
-12% -$454K 2.69% 10
2021
Q2 		$3.43M Hold
87,575
– – 2.77% 11
2021
Q1 		$3.17M Buy
+87,575
New +$3.11M 2.79% 9

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

Werlinich Asset Management's PFE Position: Q2 2026 in Review

Werlinich Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 92,200 shares worth $2.22M. The position accounts for 0.85% of the portfolio, ranked #30.

Werlinich Asset Management first reported a position in PFE in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.57M in Q4 2021. 632 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Werlinich Asset Management held 92,200 shares of Pfizer worth $2.22M as of Q2 2026.
  • Werlinich Asset Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.85% of Werlinich Asset Management's portfolio in Q2 2026, its #30 holding.
  • Werlinich Asset Management first reported a position in Pfizer in Q1 2021 and has held it in 22 quarters since.
  • Werlinich Asset Management's Pfizer position peaked at $4.57M in Q4 2021.
  • 632 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Werlinich Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.